Literature DB >> 3872022

Pulmonary manifestations of juvenile laryngotracheal papillomatosis.

S S Kramer, W D Wehunt, J T Stocker, H Kashima.   

Abstract

Juvenile laryngotracheal papillomatosis spreads to involve the lungs in less than 1% of cases, and when this occurs, the prognosis is poor. In seven such cases, the lung lesions, which appeared either solid or cystic on radiographs, proved to be benign squamous cell proliferations or papillomas, with central cavities containing debris or air. They seemed to grow centrifugally, using the alveolar walls as scaffolding with central coalescence and lung destruction. Papillomas spread inferiorly from the larynx by direct extension as far as the major bronchi, but rarely beyond. However, the parenchymal lesions were widely scattered, and some were subpleural. This discrepancy suggests that fragments become detached, particularly during endoscopic resection, and are carried down the airways by airflow. Those that lodge proximal to the respiratory bronchioles may be removed by mucociliary action and cough. Those that travel more distally are poorly cleared and may grow. If enough lung parenchyma is destroyed, the patient can develop symptoms of restrictive lung disease in addition to signs of upper airway obstruction.

Entities:  

Mesh:

Year:  1985        PMID: 3872022     DOI: 10.2214/ajr.144.4.687

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Management of adult recurrent respiratory papillomatosis with oral acyclovir following micro laryngeal surgery: a case series.

Authors:  Jagdish Chaturvedi; V Sreenivas; V Hemanth; R Nandakumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-06

2.  Recurrent respiratory papillomatosis with pulmonary cystic disease in a child, following maternal genital warts.

Authors:  R T Sadikot; A C Andrew; J D Wilson; A G Arnold
Journal:  Genitourin Med       Date:  1997-02

3.  Pulmonary spread of laryngeal papillomatosis: radiological findings.

Authors:  Katsumi Abe; Yoshiaki Tanaka; Motoichiro Takahashi; Shigeru Kosuda; Katsumi Hayashi; Tetsuya Tanabe; Yoshie Iwasaki; Shinsuke Aida; Toshio Kawauchi; Masayoshi Yamamoto; Tamotsu Kita; Tatsumi Kaji
Journal:  Radiat Med       Date:  2006-05

4.  Malignant degeneration of pulmonary juvenile-onset recurrent respiratory papillomatosis.

Authors:  Benjamin R Knepper; Meryle J Eklund; Kiery A Braithwaite
Journal:  Pediatr Radiol       Date:  2014-12-07

5.  Small cell neuroendocrine carcinoma of tracheostomy site in a patient with a history of juvenile laryngeal papillomatosis.

Authors:  Victoria Violet Wilmot; Iain James Nixon; Ioanna Fragkandrea Nixon
Journal:  BMJ Case Rep       Date:  2016-08-09

Review 6.  [Laryngeal papillomatosis: etiology, diagnostics and therapy].

Authors:  M Andratschke; C Betz; A Leunig
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

Review 7.  Unusual lung tumours: an illustrated review of CT features suggestive of this diagnosis.

Authors:  K Bhatia; S Ellis
Journal:  Cancer Imaging       Date:  2006-07-04       Impact factor: 3.909

8.  A Case of the Intrapulmonary Spread of Recurrent Respiratory Papillomatosis With Malignant Transformation.

Authors:  Yang Xiao; Jun Wang; Demin Han; Lijing Ma
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

Review 9.  A solitary bronchial papilloma with unusual endoscopic presentation: case study and literature review.

Authors:  Fabrice Paganin; Martine Prevot; Jean Baptiste Noel; Marie Frejeville; Claude Arvin-Berod; Arnaud Bourdin
Journal:  BMC Pulm Med       Date:  2009-08-18       Impact factor: 3.317

10.  A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion.

Authors:  Paul-Stefan Mauz; Manola Zago; Ralf Kurth; Michael Pawlita; Martin Holderried; John Thiericke; Angelika Iftner; Frank Stubenrauch; Karl Sotlar; Thomas Iftner
Journal:  Virol J       Date:  2014-06-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.